葵花药业：维生素K1滴剂获上市许可受理

Group 1 - The core point of the article is that Kewang Pharmaceutical (002737) announced that its subsidiary, Kewang Pharmaceutical Group (Xiangyang) Longzhong Co., Ltd., has received a notice of acceptance from the National Medical Products Administration regarding the application for the registration and marketing authorization of Vitamin K1 drops [1] - The drug is classified as a Class 3 chemical drug, with the acceptance number CYHS2502534, and is intended for the prevention of vitamin K deficiency bleeding in infants [1] - The company will actively promote the marketing authorization process for this product and will continue to monitor the approval status, ensuring timely information disclosure [1]